Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes von Home, P.D, Soewondo, P, Hussein, Z, Shafie, A.A, AlRaddady, K, Baadbad, R, Hammerby, E, Nikolajsen, A, Andersen, M.F.B, Henriksen, O

Volltext

Short And Long-Term Cost-Effectiveness Of Switching Therapy From Insulin Glargine To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes In Saudi Arabia And India von Home, P.D, Soewondo, P, Shafie, A.A, AlRaddady, K, Baadbad, R, Hammerby, E, Nikolajsen, A, M.F.B., Andersen, Henriksen, O

Volltext

Short And Long-Term Cost-Effectiveness Of Starting Biphasic Insulin Aspart 30 In Insulin-Naïve People With Type-2 Diabetes von Home, P.D, Soewondo, P, Hussein, Z, Shafie, A.A, AlRaddady, K, Baadbad, R, Hammerby, E, Nikolajsen, A, M.F.B, Andersen, Henriksen, O

Volltext

PDB48 - Short And Long-Term Cost-Effectiveness Of Switching Therapy From Insulin Glargine To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes In Saudi Arabia And India von Home, P.D., Soewondo, P., Shafie, A.A., AlRaddady, K., Baadbad, R., Hammerby, E., Nikolajsen, A., M.F.B., Andersen, Henriksen, O.

Volltext

PDB49 - Short And Long-Term Cost-Effectiveness Of Starting Biphasic Insulin Aspart 30 In Insulin-Naïve People With Type-2 Diabetes von Home, P.D., Soewondo, P., Hussein, Z., Shafie, A.A., AlRaddady, K., Baadbad, R., Hammerby, E., Nikolajsen, A., M.F.B, Andersen, Henriksen, O.

Volltext

PDB47 - Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes von Home, P.D., Soewondo, P., Hussein, Z., Shafie, A.A., AlRaddady, K., Baadbad, R., Hammerby, E., Nikolajsen, A., Andersen, M.F.B., Henriksen, O.

Volltext